OmanDocSign in

Curriculum · Gastroenterology

Zollinger-Ellison syndrome (gastrinoma)

What it is

Zollinger-Ellison syndrome is a gastrin-secreting tumor of non-beta islet cells, the islet of Langerhans, and it is also set down as a gastrin-secreting cancer of the pancreas.

The chain runs one way and explains every feature: the tumor secretes gastrin, gastrin acts on the parietal cell, the parietal cell pours out hydrochloric acid, and the acid makes the ulcer. ZES is a rare but important cause of refractory or multiple PUD.

How it presents

The clinical list is abdominal pain, chronic diarrhea, dyspepsia, weight loss and GI bleeding.

Two of those together are what should raise it: multiple refractory ulcers with persistent diarrhea. Refractory duodenal ulcers and diarrhea is suggestive of ZES.

The syndrome it belongs to

ZES is associated with multiple endocrine neoplasia, MEN syndrome, and with MEN1, and that association is half the topic.

MEN-I is the three Ps: parathyroid, pituitary and pancreatic tumors, and with them hyper-Ca. So a hyper-Ca beside a refractory ulcer is not a separate problem; it comes from the parathyroid tumor of MEN-I.

How it is diagnosed

ZES is diagnosed through a finding of elevated gastrin level and elevated gastric acid output. Both are asked for together.

Serum gastrin level is the screening test, and the order given is:

The secretin test is the one named for gastrinoma, that is for Zollinger syndrome.

Insulinoma is what it is set against, since both are islet cell tumors and their tests differ. For a 32-year-old female with palpitation, tremor and blurred vision aggravated by playing tennis and relieved by eating, the gold standard is the 72-hour observed fasting test, which confirms insulinoma biochemically. There the secretin test is wrong because it is used for gastrinoma; CT scan abdomen is used after diagnosis, for localization; and a serum glucagon level is not diagnostic for hypoglycemia syndromes.